RCRC Independent Review Board Announces DHHS Research Oversight RCRC IRB announces new service -- oversight of research supported by or conducted by the US Department of Health and Human Services. Austin, TX (PRWEB) September 25, 2009 RCRC Independent Review Board, providing ethical review services for greater than 20 years, announced today that it will provide oversight of research supported or conducted by a federal department or agency within the Department of Health and Human Services (HHS). "We are very pleased to announce these new services of RCRC IRB for the clinical research community. Expanding and continually enhancing the protection of research subjects is a core value of our organization, and these efforts are an important component of our overall program," stated Priscilla Short, RCRC Executive Director. The Office for Human Research Protections (OHRP) maintains regulatory oversight of research supported or conducted by the US Department of Health and Human Services. This research is governed by HHS regulations -- Title 45, Part 46, Code of Federal Regulations (45 CFR part 46). RCRC has modified its policies to ensure compliance with these regulations. RCRC is also subject to regulation by the Food and Drug Administration (FDA) for its oversight of FDA regulated research involving drug, devices, and biologics. RCRC is registered with the US Department of Health and Human Services IRB Registration System. RCRC is a fully accredited, leading provider of professional IRB services, providing IRB review for clients nationwide. RCRC provides ethical review for all phases of research in a variety of therapeutic areas and has extensive experience in single-site trials, multi-site trials and mega trials. RCRC offers two weekly review board meetings and a 24-48 hour turnaround time. For further information visit http://www.rcrc-irb.com. For Additional Information Contact Priscilla Short
###
|
© Copyright 1997-2012, Vocus PRW Holdings, LLC. |